Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
<h3>Background</h3> The optimal use of various therapeutic combinations for moderate/severe chronic obstructive pulmonary disease (COPD) is unclear. The GLISTEN trial compared the efficacy of two long-acting anti-muscarinic antagonists (LAMA), when combined with an inhaled corticosteroid...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2015
|
| 在线阅读: | https://doi.org/10.1136/thoraxjnl-2014-206670 https://thorax.bmj.com/content/thoraxjnl/70/6/519.full.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|